Hot-spot empowered gold nanoparticles for theranostics in breast cancer
Theranostics · 30.08.2025 · 15 (18) · 9695-9728
DOI: 10.7150/thno.119678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 30.08.2025. Verfasst von Meng Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering & School of Science, Harbin Institute of Technology, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Gold, Theranostic Nanomedicine, Metal Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Breast cancer, being the most prevalent malignant tumor among women, confronts severe challenges in its early detection and precise treatment. Traditional diagnostic approaches have drawbacks in terms of sensitivity and specificity, and are invasive, thereby making it arduous to satisfy practical demands. Nanomedicine has introduced novel diagnostic and therapeutic modalities for breast cancer, particularly gold nanoparticles (AuNPs), which have been utilized on account of their distinctive optical and physicochemical attributes. Hot-spot empowered AuNPs have rapidly emerged and demonstrated significant potential in the diagnosis and treatment of breast cancer. From a technical standpoint, the design and synthesis of AuNPs hot-spot are constantly evolving, ranging from the control of number to the control of structure and efficient control of hot-spot utilizations, establishing a development model of "number-structure-efficient utilization". Hot-spot empowered AuNPs are extensively employed in diagnosis and therapy, facilitating targeted drug delivery, photothermal and photodynamic therapy, and multimodal integration therapy, and also achieving the function of theranostics in an innovative manner. We have deliberated on the challenges and future development prospects of precision medicine for the diagnosis of early breast cancer and individualized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering & School of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
- Shenzhen Keyto Fluid Technology Co., Shenzhen, 518100, China.
- Centre for Translational Medicine, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518108, China.
- School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China.
- Key Laboratory of Science and Engineering for the Multi-modal Prevention and Control of Major Chronic Diseases, Ministry of Industry and Information Technology, HIT Zhengzhou Research Institute, Zhengzhou, 450000, China.
- Biosen International and Briteley Institute of Life Sciences, Shandong, 264600, China.
Zitieren
APA
Tian, M., Hu, S., Sun, W., Hu, Y., & Ma, X. (2025). Hot-spot empowered gold nanoparticles for theranostics in breast cancer. Theranostics, 15(18), 9695-9728. https://doi.org/10.7150/thno.119678
Vancouver
Tian M, Hu S, Sun W, Hu Y, Ma X. Hot-spot empowered gold nanoparticles for theranostics in breast cancer. Theranostics. 2025;15(18):9695-9728. doi:10.7150/thno.119678
BibTeX
@article{Tian2025,
author = {Tian, Meng and Hu, Shiqi and Sun, Wen and Hu, Ying and Ma, Xingyi},
title = {Hot-spot empowered gold nanoparticles for theranostics in breast cancer},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {18},
pages = {9695--9728},
doi = {10.7150/thno.119678}
}
EUVIMED